NVO ends its deal with HIMS over safety concerns tied to compounded Wegovy, hitting patient access and market share plans.

CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

Beyond current successes, Eli Lilly is innovating with a potential game-changing oral GLP-1, orforglipron. Read why I ...

Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...

The healthcare sector is dominated by massive players, but few are as influential as UnitedHealth Group Incorporated UNH and ...

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition By Annika Kim Constantino, CNBC and Ashley Capoot, CNBC • Published June 11, 2025 • Updated on June 11, 2025 at 2 ...

It's just over a week since pharmacy benefit managers CVS and Express Scripts sued the state of Arkansas over a new monopoly-busting law prohibiting PBMs—middle ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s Disruptor 50 List.

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...